Zhuo, L. S.;# Xu, H. C.;# Wang, M. S.;# Zhao, X. E.; Ming, Z. H.; Zhu, X. L.; Huang, W.*; Yang, G. F.* 2,7-Naphthyridinone-Based MET Kinase Inhibitors: A Promising Novel Scaffold for Antitumor Drug Development. Eur. J. Med. Chem. 2019, 178, 705-714. (IF2019 = 5.572，一区)
Release Time:2026-06-15
Hits:
- Date:
- 2026-06-15
- Title of Paper:
- Zhuo, L. S.;# Xu, H. C.;# Wang, M. S.;# Zhao, X. E.; Ming, Z. H.; Zhu, X. L.; Huang, W.*; Yang, G. F.* 2,7-Naphthyridinone-Based MET Kinase Inhibitors: A Promising Novel Scaffold for Antitumor Drug Development. Eur. J. Med. Chem. 2019, 178, 705-714. (IF2019 = 5.572，一区)
- Translation or Not:
- No
- Prev One:Wang, M. S.;# Zhuo, L. S.;# Yang, F. P.;# Wang, W. J.; Huang, W.*; Yang, G. F.* Synthesis and biological evaluation of new MET inhibitors with 1,6-naphthyridinone scaffold. Eur. J. Med. Chem. 2020, 185, 111803. (IF2020 = 6.514，一区)
- Next One:Wang, Y. Z.;* Huang, W.;* Xin, M. H.; Chen, P.; Gui, L.; Zhao, X. X.; Zhu, X. R.; Tang, F.; Luo, H. P.; Cong, X.; Wang, J.; Liu, F.;* Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors. Bioorg. Med. Chem. 2019, 27, 2592-2597. (IF2019 = 3.073，二区)